Asthma and Allergy

Card Set Information

Author:
kyleannkelsey
ID:
288832
Filename:
Asthma and Allergy
Updated:
2014-11-10 20:10:21
Tags:
Asthma Allergy
Folders:
Asthma and Allergy
Description:
Asthma and Allergy
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user kyleannkelsey on FreezingBlue Flashcards. What would you like to do?


  1. what causes intrinsic allergies?
    non-allergenic activities (e.g. exercise) - IgE-independent
  2. what causes extrinsic allergies?
    allergens that are inhaled - IgE-dependent
  3. what is the definitive test for asthma?
    • methacholine challenge
    • asthma triad of symptoms
    • bronchoconstrictionmucus production
    • fluid accumulation (edema)
  4. what 3 cytokines released by TH2 activate B cells?
    • IL-4
    • IL-5
    • IL-13
  5. what are some features of airway remodeling?
    • more goblet cells
    • fewer cilia
    • submucosal gland hypertrophy
  6. cilia beat slower at which airway: distal or proximal?
    distal
  7. histamine: site of action and function
    • site: airway smooth muscle
    • function: bronchoconstriction
  8. prostaglandins: site of action and function
    • site: glands
    • function: mucus secretion
  9. leukotrienes: site of action and function
    • site: capillaries
    • function: edema
  10. what allergenic mediators are responsible for bronchoconstriction?
    histamine, bradykinin, Leukotrienes
  11. which mediator produces bronchoconstriction via C-fiber stimulation?
    bradykinin
  12. what is the function of C-fibers?
    stimulated by allergenic mediators to cause reflex bronchoconstriction and local release of neuropeptides
  13. in asthma, the SNS causes: relaxation or bronchoconstriction? how?
    • relaxation
    • releases ACh/NE to activate beta-2 receptors
  14. what are the 2 mediators of NANC-I?
    VIP and NO
  15. does NO cause bronchoconstriction or relaxation?
    • both
    • relaxation (dilation) at low levels and constriction at high levels
  16. this parasympathetic mediator causes bronchodilation at low levels and bronchoconstriction at high levels
    NO
  17. which is associated with O2 radicals and inflammation: eNOS or iNOS?
    iNOS
  18. which is present in nanomolar concentrations: eNOS or iNOS?
    iNOS
  19. which mast cell mediator degrades VIP leading to increased ACh effects and bronchoconstriction?
    tryptase
  20. what are the 2 mediators of NANC-E?
    substance P and neurokinin A (tachykinins)
  21. what are the steps of the early phase of asthma?
    • 1. antigen inhalation --> phagocytosis by macrophages
    • 2. macrophages present antigen to T cells --> activation of B cells
    • 3. B cells release IgE
    • 4. antigen cross-links with mast cells to activate C-fibers
    • 5. mast cell degranulation --> symptom triad (constriction, mucus, edema) and chemotaxis
  22. what are the steps of the late phase of asthma?
    • 1. leukocyte degranulation
    • 2. bronchoconstriction and inflammation
  23. MOA of glucocorticoids
    decrease late phase rxn by activating adenyl cyclase --> relaxation and reduced mast cell mediator release
  24. which drug class works by activating adenyl cyclase?
    glucocorticoids
  25. do glucocorticoids affect the early or late phase of asthma response?
    late
  26. oral thrush and dysphonia are associated with which asthma drug(s)?
    glucocorticoids
  27. IgG monoclonal antibody that decreases sensitivity to inhaled allergens
    omalizumab
  28. omalizumab MOA
    depletes free IgE on basophils, mast cells and dendritic cells
  29. omalizumab indication
    >11 yrs when glucocorticoids are not effective
  30. omalizumab s/e
    • anaphylaxis (rare)
    • decreased cancer responsiveness
  31. ADCC preferentially uses: IgE, IgG or IgM?
    IgE
  32. MOA of ADCC
    IgE binds to NK cell to direct it to the targeted cell to be killed
  33. MOA of specific allergen immunotherapy (SIT)
    • -induces CD4CD25 (regulatory) T cells so tolerance occurs
    • -cellular immune response instead of humoral
  34. specific allergen immunotherapy (SIT) induces which type of immune cells?
    CD4CD25 (regulatory) T cells
  35. sublingual allergen immunotherapy is more effective for seasonal or perennial allergies?
    seasonal
  36. indication for Oralair?
    allergic rhinitis in response to any of 5 grass pollens
  37. what causes food allergy?
    immune response to food proteins
  38. nonspecific vs specific mechanism of food allergy
    • nonspecific: mucin coat in GI tract prevents absorption of antigens
    • specific: IgA neutralizes antigens
  39. which Ig is associated with food allergies: IgE, IgG or IgA?
    IgA
  40. major immune cell involved with food allergies
    basophils
  41. tx for food allergies?
    PO and SL immunotherapy (SIT)

What would you like to do?

Home > Flashcards > Print Preview